Gainers (% change)     

Back to dashboard
Company Name Symbol Price Prev. Close Volume Change % Change
Fusion Pharmaceuticals Inc  FUSN 5.460 4.850 16,845
+0.61
+12.58%
Pinduoduo Inc ADR  PDD 63.03 56.01 17,342,164
+7.02
+12.53%
Digital Brands Group Inc  DBGI 2.430 2.160 425,907
+0.27
+12.50%
Momentive Global Inc  MNTV 21.60 19.20 4,446,311
+2.40
+12.50%
Repare Therapeutics Inc  RPTX 22.78 20.27 235,116
+2.51
+12.38%
Verifyme Inc  VRME 3.550 3.160 99,822
+0.39
+12.34%
Intrusion Inc  INTZ 3.680 3.280 95,923
+0.40
+12.20%
Lightpath Tech Inc  LPTH 2.120 1.890 664,306
+0.23
+12.17%
Recursion Pharmaceuticals Inc Cl A  RXRX 20.72 18.48 3,148,161
+2.24
+12.12%
Pacific Biosciences  PACB 22.63 20.19 3,670,287
+2.44
+12.10%
Oncosec Medical  ONCS 1.390 1.240 467,724
+0.15
+12.10%
Nkarta Inc  NKTX 15.48 13.82 264,023
+1.66
+12.01%
Vir Biotechnology Inc  VIR 42.98 38.39 1,854,783
+4.59
+11.96%
Digital Turbine  APPS 55.73 49.80 7,059,574
+5.93
+11.91%
Hutchmed China Ltd ADR  HCM 32.33 28.89 555,843
+3.44
+11.91%
Taysha Gene Therapies Inc  TSHA 14.48 12.95 158,533
+1.53
+11.81%
Centrus Energy Corp  LEU 56.49 50.54 169,307
+5.95
+11.77%
Everspin Technologies Inc  MRAM 11.78 10.54 546,288
+1.24
+11.76%
Resonant Inc  RESN 2.000 1.790 1,390,885
+0.21
+11.73%
Redhill Biophrma ADR  RDHL 2.960 2.650 868,931
+0.31
+11.70%
Vallon Pharmaceuticals Inc  VLON 5.560 4.980 210,352
+0.58
+11.65%
Maxcyte Inc  MXCT 11.04 9.890 928,230
+1.15
+11.63%
Braze, Inc. - Class A Common Stock  BRZE 66.65 59.73 149,950
+6.92
+11.59%
Omeros Corp  OMER 7.629 6.840 1,307,651
+0.79
+11.54%
Troika Media Group Inc  TRKA 1.450 1.300 1,127,097
+0.15
+11.54%
Sigilon Therapeutics Inc  SGTX 3.190 2.860 177,657
+0.33
+11.54%
Surface Oncology Inc  SURF 5.710 5.120 863,007
+0.59
+11.52%
Maxlinear Inc  MXL 73.61 66.05 838,227
+7.56
+11.45%
Prothena Corp  PRTA 49.10 44.06 491,142
+5.04
+11.44%
First Wave Biopharma Inc  FWBI 1.560 1.400 646,006
+0.16
+11.43%
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.